|
20 Companies |
|
23 Products |
|
23 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
276 News |
|
| 123456» |
- | Trial completion, Enrollment change, Surgery: Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery (clinicaltrials.gov) - Nov 16, 2018
P=N/A, N=154, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed | N=720 --> 154
- | Trial completion: Antioxidants for Prevention of Cataracts Follow-up Study (clinicaltrials.gov) - Oct 30, 2018
P=N/A, N=576, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=720 --> 154 Enrolling by invitation --> Completed
- | Trial completion date, Trial primary completion date: Antioxidants for Prevention of Cataracts Follow-up Study (clinicaltrials.gov) - Oct 26, 2018
P=N/A, N=798, Enrolling by invitation, Sponsor: University of California, San Francisco
Enrolling by invitation --> Completed Trial completion date: May 2018 --> Jun 2019 | Trial primary completion date: Feb 2018 --> Jun 2019
- | Enrollment change: Depth of Focus Comparison Between Acrysof IQ and Acrysof Natural IOLs (clinicaltrials.gov) - Jun 7, 2018
P=N/A, N=0, Withdrawn, Sponsor: Medical University of South Carolina
Trial completion date: May 2018 --> Jun 2019 | Trial primary completion date: Feb 2018 --> Jun 2019 N=50 --> 0
- | Enrollment change, Surgery: Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation (clinicaltrials.gov) - Jun 7, 2018
P4, N=0, Withdrawn, Sponsor: Medical University of South Carolina
N=50 --> 0 N=20 --> 0
- | Gatiflox (gatifloxacin) / Orient Europharma
Enrollment change, Trial withdrawal, Surgery: Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery (clinicaltrials.gov) - May 2, 2018
P=N/A, N=0, Withdrawn, Sponsor: Queen's University
N=20 --> 0 N=30 --> 0 | Suspended --> Withdrawn
- | Phase classification, Enrollment change: Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts (clinicaltrials.gov) - Apr 6, 2018
P, N=3432, Completed, Sponsor: National Eye Institute (NEI)
N=30 --> 0 | Suspended --> Withdrawn Phase classification: P=N/A --> P | N=873 --> 3432
- | Trial completion, Phase classification, Combination therapy, Surgery: A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=47, Completed, Sponsor: Glaukos Corporation
Phase classification: P=N/A --> P | N=873 --> 3432 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- | Phase classification, Surgery: Clinical Evaluation of a New Viscoelastic for Cataract Surgery (clinicaltrials.gov) - Feb 24, 2018
P=N/A, N=400, Completed, Sponsor: Abbott Medical Optics
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Phase classification: P3 --> P=N/A
- | Trial primary completion date, Surgery: Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=720, Recruiting, Sponsor: Johns Hopkins University
Phase classification: P3 --> P=N/A Trial primary completion date: May 2017 --> Dec 2018
- | Trial completion: Cataract Removal and Alzheimer's Disease (clinicaltrials.gov) - Nov 9, 2017
P=N/A, N=122, Completed, Sponsor: University Hospitals Cleveland Medical Center
Trial primary completion date: May 2017 --> Dec 2018 Active, not recruiting --> Completed
- | Trial completion, Phase classification, Surgery: Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m (clinicaltrials.gov) - Jul 13, 2017
P=N/A, N=245, Completed, Sponsor: University of Zurich
Active, not recruiting --> Completed Terminated --> Completed | Phase classification: P4 --> PN/A
- | Trial completion: Pilot Study: Dynamic Light Scattering Device for Studying Early Changes in Cataract (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=15, Completed, Sponsor: National Eye Institute (NEI)
Terminated --> Completed | Phase classification: P4 --> PN/A Active, not recruiting --> Completed
- | Trial completion: Prevalence and Risk of Cataracts in Granulocyte Donors (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=252, Completed, Sponsor: National Eye Institute (NEI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial primary completion date: Antioxidants for Prevention of Cataracts Follow-up Study (clinicaltrials.gov) - Jun 12, 2017
P=N/A, N=798, Enrolling by invitation, Sponsor: University of California, San Francisco
No longer recruiting --> Completed Trial primary completion date: Feb 2017 --> Feb 2018
- | Trial completion, Enrollment change, Surgery: Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=55, Completed, Sponsor: Eye Clinic Medic Zuljan Jukic
Trial primary completion date: Feb 2017 --> Feb 2018 Enrolling by invitation --> Completed | N=120 --> 55
- | Triesence (triamcinolone acetonide injectable suspension) / Novartis, Avastin (bevacizumab) / Roche
Trial completion, Surgery: PREMED: PRevention of Macular EDema After Cataract Surgery (clinicaltrials.gov) - Apr 14, 2017
P3, N=1127, Completed, Sponsor: Maastricht University Medical Center
Enrolling by invitation --> Completed | N=120 --> 55 Recruiting --> Completed
- | Phase classification, Surgery: IOL et sommeil: Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=400, Completed, Sponsor: University Hospital, Tours
Recruiting --> Completed Phase classification: P3 --> P=N/A
- ||| Trial completion, Phase classification, Trial primary completion date, Surgery: Hydrus II: Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery. (clinicaltrials.gov) - Feb 24, 2017
P=N/A, N=100, Completed, Sponsor: Ivantis, Inc.
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Sep 2014 --> Aug 2015
- Trial completion, Enrollment change, Trial primary completion date, Surgery: Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study (clinicaltrials.gov) - Feb 13, 2017
P=N/A, N=55, Completed, Sponsor: Prim. Prof. Dr. Oliver Findl, MBA
Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Sep 2014 --> Aug 2015 Recruiting --> Completed | N=20 --> 55 | Trial primary completion date: Mar 2015 --> Aug 2015
- | Trial completion, Trial primary completion date, HEOR, Surgery: FEMCAT: Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery (clinicaltrials.gov) - Feb 3, 2017
P3, N=920, Completed, Sponsor: University Hospital, Bordeaux
Recruiting --> Completed | N=20 --> 55 | Trial primary completion date: Mar 2015 --> Aug 2015 Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2016
- Phase classification, Enrollment change, Surgery: The Influence of Vision on Balance, Gait and Falls (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=148, Completed, Sponsor: Norwegian University of Science and Technology
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2016 Phase classification: P1/2 --> P=N/A | N=400 --> 148
- Enrollment closed, Enrollment change, Trial primary completion date: Cataract Removal and Alzheimer's Disease (clinicaltrials.gov) - Nov 21, 2016
P=N/A, N=122, Active, not recruiting, Sponsor: University Hospitals Cleveland Medical Center
Phase classification: P1/2 --> P=N/A | N=400 --> 148 Recruiting --> Active, not recruiting | N=210 --> 122 | Trial primary completion date: Jun 2016 --> Jan 2017
- Enrollment open, Trial primary completion date, Surgery: Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery (clinicaltrials.gov) - Aug 31, 2016
P=N/A, N=720, Recruiting, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | N=210 --> 122 | Trial primary completion date: Jun 2016 --> Jan 2017 Not yet recruiting --> Recruiting | Trial primary completion date: May 2016 --> May 2017
- Trial completion, Video, Surgery: Video-assisted Informed Consent for Cataract Surgery (clinicaltrials.gov) - Aug 11, 2016
P=N/A, N=80, Completed, Sponsor: Guangzhou First Municipal People’s Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: May 2016 --> May 2017 Recruiting --> Completed
- Trial primary completion date, Surgery: Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=120, Enrolling by invitation, Sponsor: Eye Clinic Medic Zuljan Jukic
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Oct 2016
- Trial completion, Enrollment change, Surgery: Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls (clinicaltrials.gov) - Jul 28, 2016
P=N/A, N=49, Completed, Sponsor: Barnes Retina Institute
Trial primary completion date: Jun 2016 --> Oct 2016 Recruiting --> Completed | N=105 --> 49
- Trial completion, Enrollment change: Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts (clinicaltrials.gov) - May 28, 2016
P=N/A, N=873, Completed, Sponsor: National Eye Institute (NEI)
Recruiting --> Completed | N=105 --> 49 Recruiting --> Completed | N=5000 --> 873
- Trial primary completion date: Antioxidants for Prevention of Cataracts Follow-up Study (clinicaltrials.gov) - May 21, 2016
P=N/A, N=798, Enrolling by invitation, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=5000 --> 873 Trial primary completion date: Feb 2016 --> Feb 2017
- | trientine / Generic mfg.
Trial initiation date, Trial primary completion date, Surgery: Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - May 21, 2016
P2, N=40, Not yet recruiting, Sponsor: University of British Columbia
Trial primary completion date: Feb 2016 --> Feb 2017 Initiation date: Jun 2014 --> Mar 2017 | Trial primary completion date: Jul 2014 --> Dec 2017
- Trial primary completion date, Surgery: Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy (clinicaltrials.gov) - May 13, 2016
P=N/A, N=120, Enrolling by invitation, Sponsor: Eye Clinic Medic Zuljan Jukic
Initiation date: Jun 2014 --> Mar 2017 | Trial primary completion date: Jul 2014 --> Dec 2017 Trial primary completion date: May 2013 --> Jun 2016
- Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population (clinicaltrials.gov) - May 13, 2016
P=N/A, N=238, Completed, Sponsor: The Hong Kong Polytechnic University
Trial primary completion date: May 2013 --> Jun 2016 Not yet recruiting --> Completed | N=420 --> 238 | Initiation date: Jul 2010 --> Nov 2009 | Trial primary completion date: Dec 2011 --> Apr 2012
- | Trial completion, Trial primary completion date: Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy (clinicaltrials.gov) - Apr 1, 2016
P1, N=16, Completed, Sponsor: Croma-Pharma GmbH
Not yet recruiting --> Completed | N=420 --> 238 | Initiation date: Jul 2010 --> Nov 2009 | Trial primary completion date: Dec 2011 --> Apr 2012 Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Apr 2014
- || Trial initiation date, Surgery: COMPASS: Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=897, Completed, Sponsor: Transcend Medical, Inc.
Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Apr 2014 Initiation date: Jul 2011 --> Sep 2009
- Trial completion, Enrollment change, Trial primary completion date: Efficacy of Lutein, Zeaxanthine and Trypan Blue to Stain the Anterior Lens Capsule (clinicaltrials.gov) - Mar 17, 2016
P3, N=25, Completed, Sponsor: Federal University of São Paulo
Initiation date: Jul 2011 --> Sep 2009 Recruiting --> Completed | N=20 --> 25 | Trial primary completion date: Jul 2012 --> Jul 2013
- ||| Trial completion, Enrollment change, Surgery: Analysis of Cataract Surgery Induced Dry Eye (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=61, Completed, Sponsor: TearLab Corporation
Recruiting --> Completed | N=20 --> 25 | Trial primary completion date: Jul 2012 --> Jul 2013 Enrolling by invitation --> Completed | N=80 --> 61
- ||||||| Sonsuvi (brimapitide) / Xigen, Auris Medical
Trial completion, Trial primary completion date, Surgery: Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation (clinicaltrials.gov) - Jan 11, 2016
P3, N=339, Completed, Sponsor: Xigen SA
Enrolling by invitation --> Completed | N=80 --> 61 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2015
- |||| RX-10045 / Auven Therap, Resolvyx
Trial completion, Trial primary completion date, Surgery: Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery (clinicaltrials.gov) - Dec 29, 2015
P2, N=256, Completed, Sponsor: A.T. Resolve SARL
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Sep 2015
- Trial completion, Combination therapy: Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses. (clinicaltrials.gov) - Dec 15, 2015
P4, N=15, Completed, Sponsor: Charite University, Berlin, Germany
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Sep 2015 Recruiting --> Completed
- | Trial completion: The Post-Vitrectomy Lenstatin™ Study (clinicaltrials.gov) - Dec 6, 2015
P=N/A, N=20, Completed, Sponsor: Lenstatin LLC
Recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Cataract Removal and Alzheimer's Disease (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=210, Recruiting, Sponsor: University Hospital Case Medical Center
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2016
- Ozurdex (dexamethasone intravitreal implant) / AbbVie
Trial completion, Surgery: The Effect of Intravitreal Ozurdex on DME After Cataract Surgery (clinicaltrials.gov) - Dec 4, 2015
P3, N=24, Completed, Sponsor: University Health Network, Toronto
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Completed
- Trial completion: Natural History in CCFDN and IBM Syndromes (clinicaltrials.gov) - Sep 2, 2015
P=N/A, N=350, Completed, Sponsor: Ludwig-Maximilians - University of Munich
Recruiting --> Completed Enrolling by invitation --> Completed
- Trial completion, Trial primary completion date, Surgery: Combined Cataract Surgery and Planned Descemetorhexis (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=2, Completed, Sponsor: Medical College of Wisconsin
Enrolling by invitation --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015
- Trial completion, Trial primary completion date, Surgery: The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser. (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=45, Completed, Sponsor: Steve H. Linn, OD
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Dec 2013
- ||| Trial completion: Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9 (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=477, Completed, Sponsor: Alcon Research
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Dec 2013 Active, not recruiting --> Completed
- || Trial initiation date, Surgery: COMPASS: Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery (clinicaltrials.gov) - Jul 20, 2015
P=N/A, N=897, Completed, Sponsor: Transcend Medical, Inc.
Active, not recruiting --> Completed Initiation date: Sep 2009 --> Jul 2011
- |||| Skyclarys (omaveloxolone) / Biogen
Trial completion, Surgery: RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD (clinicaltrials.gov) - Jul 16, 2015
P2, N=304, Completed, Sponsor: Reata Pharmaceuticals, Inc.
Initiation date: Sep 2009 --> Jul 2011 Active, not recruiting --> Completed
- Trial completion, Surgery: The Effects of Medical Clowning on Blood Pressure and Pulse Rate of Patients Undergoing Cataract Surgery Under Local Anesthesia (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=100, Completed, Sponsor: HaEmek Medical Center, Israel
Active, not recruiting --> Completed Recruiting --> Completed
- Nevanac (nepafenac) / Novartis
Trial primary completion date, Surgery: Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=50, Recruiting, Sponsor: Melissa Toyos, MD
Recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015